COVID-19: Operations continue at the ASC
On March 23, 2020, the ASC and our colleagues in the CSA published temporary blanket relief for market participants from certain regulatory filings, as a result of COVID-19. More information about this blanket relief, including who to call if you have questions, is available here and through these FAQs, published on April 3.
All organizations and individuals sharing documents with us are encouraged to provide them electronically via email, so we are able to process them while working remotely. The appropriate email addresses and phone numbers are listed here. Don’t hesitate to call us if you have questions. Our virtual reception remains open at (403) 297-6454, however we are working remotely and our physical reception is closed to the public.
Our inquiries line, complaints system and Office of the Whistleblower remain operational. However, there may be some minor delays in answering your call. Please leave a message, your call will be returned in a timely fashion.
The ASC is an essential service and is committed to delivering on our mandate to foster a fair and efficient capital market and protect investors. We are monitoring the evolving COVID-19 pandemic and its impact on the capital markets, following the protocols outlined by local authorities and committed to the health and welfare of our employees and our community. In conjunction with our colleagues across the Canadian Securities Administrators (CSA), our team remains focused on supporting market participants, protecting investors and assisting the public. Information about regulatory or other updates related to COVID-19 will be posted on this webpage as it becomes available.
News releases
Investor alerts
Additional resources
CSA Guidance - COVID-19 Continuous Disclosure Obligations and Considerations for Issuers
If you have any questions or concerns, please do not hesitate to contact us.
Click the button below if you are an investor looking for more information to protect yourself:
If you are a market participant looking for regulatory updates, click here.